ARCHIVES

Risk Assessment Key In Long-Term Treatment

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

House Democrat Seeks Funds for NCI to Pursue 2015 Goal.

June 30, 2006

President Sppointed John Niederhuber NCI Director.

September 8, 2006

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984